Waldron Private Wealth’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-852
| Closed | -$314K | – | 341 |
|
2024
Q4 | $314K | Sell |
852
-291
| -25% | -$107K | 0.01% | 324 |
|
2024
Q3 | $594K | Buy |
1,143
+77
| +7% | +$40K | 0.02% | 229 |
|
2024
Q2 | $578K | Buy |
1,066
+63
| +6% | +$34.1K | 0.03% | 210 |
|
2024
Q1 | $520K | Sell |
1,003
-37
| -4% | -$19.2K | 0.02% | 235 |
|
2023
Q4 | $490K | Sell |
1,040
-60
| -5% | -$28.3K | 0.02% | 236 |
|
2023
Q3 | $479K | Sell |
1,100
-401
| -27% | -$175K | 0.02% | 238 |
|
2023
Q2 | $667K | Buy |
1,501
+514
| +52% | +$228K | 0.03% | 197 |
|
2023
Q1 | $454K | Sell |
987
-20
| -2% | -$9.2K | 0.02% | 267 |
|
2022
Q4 | $457K | Hold |
1,007
| – | – | 0.03% | 247 |
|
2022
Q3 | $457K | Buy |
1,007
+25
| +3% | +$11.3K | 0.03% | 247 |
|
2022
Q2 | $473K | Buy |
982
+11
| +1% | +$5.3K | 0.03% | 250 |
|
2022
Q1 | $476K | Buy |
971
+244
| +34% | +$120K | 0.02% | 259 |
|
2021
Q4 | $336K | Buy |
727
+2
| +0.3% | +$924 | 0.02% | 296 |
|
2021
Q3 | $270K | Hold |
725
| – | – | 0.02% | 301 |
|
2021
Q2 | $276K | Sell |
725
-15
| -2% | -$5.71K | 0.02% | 287 |
|
2021
Q1 | $265K | Sell |
740
-41
| -5% | -$14.7K | 0.02% | 255 |
|
2020
Q4 | $250K | Buy |
781
+32
| +4% | +$10.2K | 0.02% | 256 |
|
2020
Q3 | $201K | Buy |
+749
| New | +$201K | 0.02% | 259 |
|
2019
Q2 | – | Sell |
-842
| Closed | -$241K | – | 251 |
|
2019
Q1 | $241K | Buy |
842
+51
| +6% | +$14.6K | 0.03% | 220 |
|
2018
Q4 | $207K | Buy |
+791
| New | +$207K | 0.03% | 199 |
|